Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Salvia divinorum , whose main active ingredient is the neoclerodane diterpene Salvinorin A, is a hallucinogenic plant in the mint family that has been used in traditional spiritual practices for its psychoactive properties by the Mazatecs of Oaxaca, Mexico. More recently, S. divinorum extracts and Salvinorin A have become more widely used in the U.S. as legal hallucinogens. We discovered that Salvinorin A potently and selectively inhibited 3 H-bremazocine binding to cloned κ opioid receptors. Salvinorin A had no significant activity against a battery of 50 receptors, transporters, and ion channels and showed a distinctive profile compared with the prototypic hallucinogen lysergic acid diethylamide. Functional studies demonstrated that Salvinorin A is a potent κ opioid agonist at cloned κ opioid receptors expressed in human embryonic kidney-293 cells and at native κ opioid receptors expressed in guinea pig brain. Importantly, Salvinorin A had no actions at the 5-HT 2A serotonin receptor, the principal molecular target responsible for the actions of classical hallucinogens. Salvinorin A thus represents, to our knowledge, the first naturally occurring nonnitrogenous opioid-receptor subtype-selective agonist. Because Salvinorin A is a psychotomimetic selective for κ opioid receptors, κ opioid-selective antagonists may represent novel psychotherapeutic compounds for diseases manifested by perceptual distortions (e.g., schizophrenia, dementia, and bipolar disorders). Additionally, these results suggest that κ opioid receptors play a prominent role in the modulation of human perception.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Salvia divinorum also is a kappa-opioid receptor agonist [113] linked to depersonalization experiences [114].”
From Treatment of dissociative identity disorder: leveraging neurobiology to optimize success (2024) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor
Chavkin, C., James, I. F., & Goldstein, A. (1982) · Science · doi:10.1126/science.6120570 · Cited by 1,168
Dynorphin-(1-13), an extraordinarily potent opioid peptide.
Goldstein, A., Tachibana, S., Lowney, L. I., Hunkapiller, M., & Hood, L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.12.6666 · Cited by 882
Psychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857
Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., & Roth, B. L. (2000) · Circulation · doi:10.1161/01.cir.102.23.2836 · Cited by 722
Self-citationEvidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents
Glennon, R. A., Titeler, M., & McKenney, J. D. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90436-3 · Cited by 631
CHARACTERIZATION OF THE k‐SUBTYPE OF THE OPIATE RECEPTOR IN THE GUINEA‐PIG BRAIN
KOSTERLITZ, H. W., PATERSON, S. J., & ROBSON, L. E. (1981) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1981.tb08749.x · Cited by 422
McGinty, J. F., Henriksen, S. J., Goldstein, A., Terenius, L., & Bloom, F. E. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.2.589 · Cited by 290
Roth, B. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00019-9 · Cited by 287
Self-citationSalvia divinorum and salvinorin A: new pharmacologic findings
Siebert, D. J. (1994) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(94)90116-3 · Cited by 279
Self-citationEnadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans
Walsh, S., Strain, E., Abreu, M., & Bigelow, G. (2001) · Psychopharmacology · doi:10.1007/s002130100788 · Cited by 258
Differential ontogeny of multiple opioid receptors (mu, delta, and kappa)
Spain, J., Roth, B., & Coscia, C. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-03-00584.1985 · Cited by 228
Self-citationNovel opiate binding sites selective for benzomorphan drugs.
Chang, K. J., Hazum, E., & Cuatrecasas, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4141 · Cited by 226
Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum(Labiatae)
Ortega, A., Blount, J. F., & Manchand, P. S. (1982) · Journal of the Chemical Society, Perkin Transactions 1 · doi:10.1039/p19820002505 · Cited by 226
Pogozheva, I. D., Lomize, A. L., & Mosberg, H. I. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77552-6 · Cited by 177
Valdes, L. J., Butler, W. M., Hatfield, G. M., Paul, A. G., & Koreeda, M. (1984) · The Journal of Organic Chemistry · doi:10.1021/jo00198a026 · Cited by 175
Shapiro, D. A., Kristiansen, K., Weiner, D. M., Kroeze, W. K., & Roth, B. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111675200 · Cited by 172
Self-citationDifferences in G-protein activation by μ- and δ-opioid, and cannabinoid, receptors in rat striatum
Sim, L. J., Selley, D. E., Xiao, R., & Childers, S. R. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00211-7 · Cited by 155
2-Substituted Tryptamines: Agents with Selectivity for 5-HT6Serotonin Receptors
Glennon, R. A., Lee, M., Rangisetty, J. B., Dukat, M., Roth, B. L., Savage, J. E., McBride, A., Rauser, L., Hufeisen, S., & Lee, D. K. H. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990550b · Cited by 149
Self-citationSalvia divinorum and the Unique Diterpene Hallucinogen, Salvinorin (Divinorin) A
Valdés, L. J. (1994) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1994.10472441 · Cited by 143
History and development of mixed opioid agonists, partial agonists and antagonists.
Martin, W. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb04700.x · Cited by 134
Roth, B. L., Shoham, M., Choudhary, M. S., & Khan, N. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.2.259 · Cited by 133
Self-citationAn open-label study of a functional opioid κ antagonist in the treatment of opioid dependence
Rothman, R. B., Gorelick, D. A., Heishman, S. J., Eichmiller, P. R., Hill, B. H., Norbeck, J., & Liberto, J. G. (2000) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(99)00074-4 · Cited by 124
Self-citationMcGinty, J., van der Kooy, D., & Bloom, F. (1984) · The Journal of Neuroscience · doi:10.1523/jneurosci.04-04-01104.1984 · Cited by 120
Mathieu-Kia, A.-M., Fan, L.-Q., Kreek, M. J., Simon, E. J., & Hiller, J. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03302-3 · Cited by 118
Gray, J. A., Sheffler, D. J., Bhatnagar, A., Woods, J. A., Hufeisen, S. J., Benovic, J., & Roth, B. L. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.5.1020 · Cited by 100
Self-citation5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation.
Roth, B. L., Palvimaki, E. P., Berry, S., Khan, N., Sachs, N., Uluer, A., & Choudhary, M. S. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12228-3 · Cited by 89
Self-citationChoudhary, M. S., Sachs, N., Uluer, A., Glennon, R. A., Westkaemper, R. B., & Roth, B. L. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08564-5 · Cited by 88
Self-citationAnanthan, S., Kezar, H. S., Carter, R. L., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990039i · Cited by 86
Valdés, L. J., Chang, H., Visger, D. C., et al. (2001) · Organic Letters · doi:10.1021/ol016820d · Cited by 81
Chavkin, C., Bakhit, C., Weber, E., & Bloom, F. E. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.24.7669 · Cited by 76
Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland
Giroud, C., Felber, F., Augsburger, M. P., et al. (2000) · Forensic Science International · doi:10.1016/s0379-0738(00)00180-8 · Cited by 70
Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor.
Xie, G. X., Meng, F., Mansour, A., Thompson, R. C., Hoversten, M. T., Goldstein, A., Watson, S. J., & Akil, H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3779 · Cited by 66
Peckys, D. B., & Hurd, Y. L. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00525-1 · Cited by 58
Adham, N., Tamm, J. A., Salon, J. A., Vaysse, P. J.-J., Weinshank, R. L., & Branchek, T. A. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90068-x · Cited by 56
Lavecchia, A., Greco, G., Novellino, E., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm991161k · Cited by 53
Opioid receptor density changes in Alzheimer amygdala and putamen
Barg, J., Belcheva, M. M., Rowiński, J., Ho, A., Burke, W. J., Chung, H. D., Schmidt, C. A., & Coscia, C. J. (1993) · Brain Research · doi:10.1016/0006-8993(93)91155-l · Cited by 45
Naltrexone Augmentation of Neuroleptics in Schizophrenia
Sernyak, M. J., Glazer, W. M., Heninger, G. R., Charney, D. S., Woods, S. W., Petrakis, I. L., Krystal, J. H., & Price, L. H. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199806000-00011 · Cited by 38
The Absolute Stereochemistry of Salvinorins
Koreeda, M., Brown, L., & Valdés, L. J. (1990) · Chemistry Letters · doi:10.1246/cl.1990.2015 · Cited by 32
The therapeutic role of naltrexone in negative symptom schizophrenia
Marchesi, G. F., Santone, G., Cotani, P., Giordano, A., & Chelli, F. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(95)00263-4 · Cited by 28
Splendidin, a new trans-clerodane from Salvia splendens
Savona, G., Paternostro, M. P., Piozzi, F., et al. (1979) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19790000533 · Cited by 27
Characterization of kappa1-opioid receptor binding in human insular cortex
Izenwasser, S., Staley, J. K., Cohn, S., & Mash, D. C. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00315-x · Cited by 17
Tritiated Etorphine and Naloxone Binding to Opioid Receptors in Caudate Nucleus in Schizophrenia
Owen, F., Bourne, R. C., Poulter, M., Crow, T. J., Paterson, S. J., & Kosterlitz, H. W. (1985) · The British Journal of Psychiatry · doi:10.1192/bjp.146.5.507 · Cited by 15
146. West African timbers. Part V. The structure of khivorin, a constituent of Khaya ivorensis
Bevan, C. W. L., Halsall, T. G., Nwaji, M. N., et al. (1962) · Journal of the Chemical Society (Resumed) · doi:10.1039/jr9620000768 · Cited by 15
Westkaemper, R. B., Runyon, S. P., Savage, J. E., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00010-5 · Cited by 14
Self-citationRothman, R. B. (1994) · Analgesia · doi:10.3727/107156994819564456 · Cited by 14
Self-citationOntogeny of benzomorphan-selective (κ) sites: A computerized analysis
Spain, J. W., Bennett, D. B., Roth, B. L., et al. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90486-1 · Cited by 13
Self-citationPartilla, J. S., Carrol, F. I., Thomas, J. B., et al. (1999) · Analgesia · doi:10.3727/107156999819565865 · Cited by 10
Thomas, J. B., Mascarella, S. W., Burgess, J. P., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00576-9 · Cited by 9
Research works printed but not linked: 3
- B L Roth, E Palvimaki, S Berry, N Khan, N Sachs, A Uluer, M Choudhary J Pharmacol Exp Ther 275, 1638–1646 (1995).
- M S Choudhary, N Sachs, A Uluer, R A Glennon, R B Westkaemper, B L Roth Mol Pharmacol 47, 450–457 (1995).
- W R Martin, C G Eades, J A Thompson, R E Huppler, P E Gilbert J Pharmacol Exp Ther 197, 517–532 (1976).
Cited by
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402
Self-citationNichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Predicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
Self-citationParkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308947200 · Cited by 913
Self-citationStructure of the human κ-opioid receptor in complex with JDTic
Wu, H., Wacker, D., Mileni, M., Katritch, V., Han, G. W., Vardy, E., Liu, W., Thompson, A. A., Huang, X.-P., Carroll, F. I., et al. (2012) · Nature · doi:10.1038/nature10939 · Cited by 879
Self-citation
Metadata
- Authors
- Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., & Rothman, R. B.
- Affiliations
- National Institutes of Health (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-08-21
- Volume
- 99
- Issue
- 18
- Pages
- 11934-11939
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC129372
- OpenAlex
- W2005643237
- Cited by
- 784
- References
- 50
- Citations by year
- 2026: 20 · 2025: 26 · 2024: 27 · 2023: 25 · 2022: 30 · 2021: 33 · 2020: 25 · 2019: 37 · 2018: 30 · 2017: 44 · 2016: 45 · 2015: 29 · 2014: 39 · 2013: 42 · 2012: 42
- FWCI
- 18.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01mh080004-000)
- National Institute of Mental Health (KO2MH01366, K02MH001366, N01 MH080004, N02MH80004)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- salvinorin A, Salvia divinorum, kappa opioid receptor, kappa opioid receptor agonists, hallucinogens, lysergic acid diethylamide, 5-HT2A receptor, psychotomimetics
- MeSH terms
- Animals, Brain, Diterpenes, Guinea Pigs, Models, Molecular, Radioligand Assay, Recombinant Proteins, Receptors, Opioid, kappa, Salvia, Diterpenes, Clerodane, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.